Ueda Y, Okano S, Enokida T, Fujisawa T, et al. Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study. Oral Oncol 2022;130:105932.
PMID: 35636078